Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
deals
fda
investing
2
×
life sciences
national blog main
achaogen
adams street partners
akouos
antibiotics
astellas pharmaceuticals
beta lactamase inhibitor
biomedical advanced research and development authority (barda)
boston
boston blog main
california institute for biomedical research
decibel therapeutics
drug resistance
drugs
frequency therapeutics
harvard university
hatteras venture partners
hearing loss
jeffrey karp
lyzz capital
macrolide pharmaceuticals
melinta therapeutics
meropenem
michael dudley
multiple sclerosis
new enterprise associates
new york blog main
perceptive life sciences
regenerative medicine
rempex pharmaceuticals
robert langer
san diego
san diego blog main
san diego top stories
What
drug
2
×
medicines
therapeutics
2
×
affects
americans
approved
bacteria
biopharma
business
company
date
developing
disease
exited
fda
fighting
frequency
hearing
infections
infectious
ipo
launches
loss
meds
melinta
millions
plans
products
qpex
regenerative
resistant
sold
tackle
treat
year
Language
unset
Current search:
investing
×
therapeutics
×
drug
×
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
